Photographer: Zoltan Mathe / AFP / Getty Images
Photographer: Zoltan Mathe / AFP / Getty Images
The Covid-19 vaccine from AstraZeneca Plc and Oxford University were 79% effective in preventing the disease in a U.S. trial, paving the way for a possible approval of the picture.
The UK drug dealer released the first data from a survey of more than 30,000 volunteers on Monday. The results are good news for older adults, who made up about a quarter of the tests, after last year’s tests failed to provide definitive data for that age group due to a lack of com- partners over 65 years of age.
The vaccine has also been proven to be 100% effective in preventing serious illness, death and hospitalization.
The findings should go a little further in strengthening confidence in the global picture after confusion over the true effectiveness of the vaccine and the best dosing regimen to influence uptake, in particular in Europe.
Tests in the UK and Brazil last year yielded a range of readings as a result of different dosing sizes and regimens used, and at least 10 EU countries only approved the picture for children under 65 years of age. first. There are many on it since he reversed that decision after more data from real-world practice showed that the bullet was very effective in the elderly.